Prescribers and Pharmaceutical Representatives: Why Are We Still Meeting?
Fischer, Melissa A
Keough, Mary Ellen
Baril, Joann L
Mazor, Kathleen M
Von Worley, Ann
Gurwitz, Jerry H
Journal of general internal medicine 2009 Jul; 24(7): 795-801
Research suggests that pharmaceutical marketing influences prescribing and may cause cognitive dissonance for prescribers. This work has primarily been with physicians and physician-trainees. Questions remain regarding why prescribers continue to meet with pharmaceutical representatives (PRs).
Showing items related by title, author, creator and subject.
Mazor, Kathleen M.; Reed, George W.; Tood, Robert A.; Fischer, Melissa A.; Baril, Joann; Gurwitz, Jerry H. (2006-07)
Ladd, Elissa C; Mahoney, Diane Feeney; Emani, Srinivas (2010-12-01)To assess nurse practitioners' interactions with pharmaceutical industry promotional activities and their perception of information reliability and self-reported prescribing behaviors.
Mazor, Kathleen M.; Simon, Steven R.; Yood, Robert A.; Martinson, Brian C.; Gunter, Margaret J.; Reed, George W.; Gurwitz, Jerry H. (2004-03-16)BACKGROUND: Various authorities and national organizations encourage disclosing medical errors, but there is little; information on how patients respond to disclosure. OBJECTIVE: To examine how the type of error, severity ...